For patients who have HER2 positive breast cancer which has spread to the brain (metastasised) the main treatment options for these brain metastases are as follows:
Whole Brain Radiotherapy (WBRT), or
Stereotactic Radiosurgery (SRS), or
This study aims to show that brain metastases are able to be controlled by SRS and/or NS without the need for WBRT.
Closing Date of Accrual
22nd December 2020
Dr Claire Phillips, Peter MacCallum Cancer Centre, VIC
Clinical Trial Registration
After a hiatus from in-person events due to COVID-19
The RAVES trial treating prostate cancer Participating in a
For over 30 years, TROG Cancer Research has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Keep up to date with TROG news, subscribe to our community newsletter.